Industry: Other Health Care (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-09 | New | $10,606,566 | $10,606,566 | Equity Only | 06b | SEC link |
| 2024-06-21 | New | $2,800,000 | $2,800,000 | Equity Only | 06b | SEC link |
| 2023-08-10 | New | $5,199,985 | $5,199,985 | Equity Only | 06b | SEC link |
| 2022-09-13 | Amended | $3,335,431 | $0 | Equity Only | 06b | SEC link |
| 2022-09-12 | New | $3,335,431 | $3,335,431 | Debt Only | 06b | SEC link |
| 2021-02-24 | New | $1,557,403 | $1,557,403 | Equity Only | 06b | SEC link |
| 2020-09-17 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| 2018-05-07 | Amended | $903,335 | $803,335 | Equity Only | 06b | SEC link |
| 2017-10-04 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Dan Albosta | Executive |
| Franz Hefti | Director |
| Stella Sarraf | Director, Executive |
| Stella Sarraf, Ph.D. | Director, Executive |
| Vincent Simmon | Director, Executive |
| Jerre Stead | Director |
| Jerre L. Stead | Director |
| Josh Swartz | Director |
| Mervyn Turner | Director |
| Mervyn Turner, Ph.D. | Director |
| Peter Whitney Vanderklish | Executive |
| Steve Young | Director |